For 130 years, the Johnson & Johnson Family of Companies has been committed to caring for people around the world. Today the Company has 265 operating companies in more than 60 countries being the most comprehensive manufacturer of health care products in the world. At Johnson & Johnson, everything begins with innovation: out of more than 71.89 billion USD in total sales in 2016, 9,1 billion were invested to support R&D. Johnson & Johnson employs approximately 132,000 people working in three company segments: Consumer Goods, Medical Devices, and Pharmaceuticals.
The Consumer segment includes a broad range of consumer health and personal care products in beauty, baby, oral care and women's health categories, as well as nutritional products and over-the-counter medicines and wellness and prevention platforms. The Medical Devices & Diagnostics segment focuses on technologies, solutions and services in cardiovascular disease, diabetes care, orthopedics, vision care, wound care, aesthetics, sports medicine, infection prevention, minimally invasive surgery, and diagnostics. The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving important unmet medical needs, including oncology, immunology, neuroscience, infectious disease, cardiovascular and metabolic diseases.
Johnson & Johnson opened its office in Russia in 1991, and now is one of the leaders in the healthcare system. Company partners with the Russian government, supporting innovative economic development and implementation of state programs Health2020 and Pharma/MedTech2020, improving the quality of life of millions of Russians.